NDC 11673-320 - Maximum Strength Daytime Severe and Nighttime Cold and Flu
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11673-320
- Manufacturer
- TARGET Corporation | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED
- Effective date
- 2023-10-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| 748L Maximum Strength Daytime Severe Nighttime Cold & Flu | TARGET Corporation | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED | 2023-10-30 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DAYTIME COLD AND FLU Maximum Strength | ACETAMINOPHEN, DEXTROMETHORPHAN HBR,GUAIFENESIN, PHENYLEPHRINE HCL | Walgreens | dbf5656b-9105-871b-e053-2995a90a4941 | 2023-01-03 | Warnings | 9D2RTI9KYH 04JA59TNSJ 362O9ITL9D 495W7451VQ |
| Glucoreg | ASCORBICUM ACIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SARCOLACTICUM ACIDUM, THIAMINUM HYDROCHLORICUM, DHEA (DEHYDROEPIANDROSTERONE), PHLORIDZINUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-LIPOICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, NADIDUM, PANTOTHENIC ACID, ACETALDEHYDE, INSULINUM (SUIS), INSULINUM (HUMAN), HEPAR SUIS, PANCREAS SUIS, PHLORIDZINUM, BARYTA OXALICA, ALLOXANUM, BERBERIS VULGARIS, CARCINOSIN, LYCOPODIUM CLAVATUM, MOMORDICA BALSAMINA, PHOSPHORICUM ACIDUM, PHOSPHORUS, | Deseret Biologicals, Inc. | 5117f980-95b8-4fc8-9425-8f6f05639437 | 2022-12-29 | Warnings | XF417D3PSL |
| Ibuprofen PM | IBUPROFEN, DIPHENHYDRAMINE HCL | TOP CARE (Topco Associates LLC) | c62c6319-65eb-37e8-e053-2a95a90a9f90 | 2022-12-28 | Warnings | TC2D6JAD40 |
| Ibuprofen PM | IBUPROFEN, DIPHENHYDRAMINE HCL | Wal-Mart Stores, Inc. | ba31970a-b952-467c-b3f8-44f7a513de34 | 2022-12-28 | Warnings | TC2D6JAD40 |
| Ibuprofen PM | IBUPROFEN, DIPHENHYDRAMINE HCL | CHAIN DRUG MARKETING ASSOCIATION INC. | c483bbd6-934b-660a-e053-2995a90a51b3 | 2022-12-27 | Warnings | TC2D6JAD40 |
| Ibuprofen PM | IBUPROFEN, DIPHENHYDRAMINE HCL | CVS Pharmacy | ce4378c0-848e-7878-e053-2a95a90af0f3 | 2022-12-27 | Warnings | TC2D6JAD40 |
| pain relief pm | IBUPROFEN, DIPHENHYDRAMINE HCL | Bionpharma Inc. | 58666a5c-fc92-4c8d-9c04-f0c98dc05c56 | 2022-12-20 | Warnings | TC2D6JAD40 |
| DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 7b9ed8ef-ce21-19e7-e053-2a91aa0a81be | 2022-12-10 | Warnings, Adverse reactions | TC2D6JAD40 |
| Diphenhydramine HCl and Ibuprofen | DIPHENHYDRAMINE HCL AND IBUPROFEN | Aurohealth LLC | 39af6dfa-e822-43a5-bd1a-338cf5da89ce | 2022-12-09 | Warnings | TC2D6JAD40 |
| Mucus Relief Extended Release Maximum Strength | GUAIFENESIN | H E B | 6f075c29-8256-4cac-96c4-a772a53ad21d | 2022-12-09 | Warnings | 495W7451VQ |
| Guaifenesin and Dextromethorphan HBr | GUAIFENESIN AND DEXTROMETHORPHAN HBR | PUBLIX SUPER MARKETS, INC | 9870b7ee-2bfb-42f5-9762-77d2dd13434a | 2022-12-06 | Warnings | 9D2RTI9KYH 495W7451VQ |
| Guaifenesin and Dextromethorphan Hydrobromide HBR | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | RITE-AID | 2343f031-d658-498a-b5d1-6dcdb26b3cf0 | 2022-12-06 | Warnings | 9D2RTI9KYH 495W7451VQ |
| Guaifenesin and Dextromethorphan HBr | GUAIFENESIN AND DEXTROMETHORPHAN HBR | SUN PHARMACEUTICAL INDUSTRIES, INC. | 06328741-03e3-49cf-ae44-d4c2116e38a3 | 2022-12-06 | Warnings | 9D2RTI9KYH 495W7451VQ |
| MAXIMUM STRENGTH Mucus D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | CVS Pharmacy | 9a560b80-972c-4af5-8fe8-eaef0b0d83b3 | 2022-12-01 | Warnings | 495W7451VQ |
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | PDC6A3C0OX |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | PDC6A3C0OX |
| GUAIFENESIN | GUAIFENESIN | CVS | 4efa8bf9-3394-47b4-b630-9476b15d2dfc | 2022-11-23 | Warnings | 495W7451VQ |
| Mucus Relief Extended Release | GUAIFENESIN | Care One (American Sales Company) | 96569c70-0936-4041-ab32-2b2262402f34 | 2022-11-21 | Warnings | 495W7451VQ |
| Mucus Relief Maximum Strength | GUAIFENESIN | Care One (American Sales Company) | c94e3943-20da-4bd4-b0ff-6aa60b03a1bf | 2022-11-21 | Warnings | 495W7451VQ |
| Mucus Relief | GUAIFENESIN | McKesson Corporation dba SKY Packaging | 69b61f05-8f0b-420f-b4ef-df933b70eebc | 2022-11-21 | Warnings | 495W7451VQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.